合成生物学市场规模、份额和成长分析：按工具、技术、应用和地区划分 - 产业预测，2024-2031 年

2022年全球合成生物学市场规模将为113亿美元，从2023年的141.8亿美元成长到2031年的872.7亿美元，预计在预测期（2024-2031年）复合年增长率为25.5%。

合成生物学市场预计在未来几年将出现强劲成长，这主要是由技术创新和对永续替代品需求不断增长的推动。基因编辑技术（特别是 Cas9 和 CRISPR）的重大进步，以及合成基因合成的改进，正在使合成生物学应用更有效率和更具成本效益。随着环境问题和永续性的日益突出，人们对绿色化学品、生物分解性材料和生质燃料等永续解决方案的兴趣日益浓厚，进一步推动了这一趋势。然而，它面临着伦理和监管障碍带来的挑战，包括基因改造、环境影响和生物安全争论，这可能会阻碍商业化和正在进行的研究倡议。儘管有这些障碍，乐观情绪仍然存在。特别是，先进治疗和个人化医疗的出现有望透过解决以前无法治疗的疾病来彻底改变医疗保健。因此，合成生物学市场正处于十字路口，技术进步和社会需求推动创新，而法律规范也不断发展以解决伦理问题。

目录

介绍

• 研究目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 二手资料来源和主要资料来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 技术分析
• 专利分析
• 价格分析
• 监管分析
• 价值链分析
• 市场生态系统
• 创新矩阵
• 主要投资分析
• 关键成功因素
• 竞争程度

合成生物学市场：依工具分类

• 市场概况
• 寡核苷酸/合成DNA
• 酵素
• 克隆技术套件
• 合成细胞
• 底盘有机体
• 异源核酸

合成生物市场：依技术分类

• 市场概况
• 基因合成
• 基因组工程
• 定序、生物资讯学
• 特异性诱变
• 复製
• 测量/建模
• 微流体
• 奈米科技

合成生物市场：依应用分类

• 市场概况

合成生物学市场规模：按地区

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 义大利
  • 法国
  • 英国
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• [if!supportLists][endif]Thermo Fisher Scientific, Inc.（US）
• Merck KGaA（Germany）
• Agilent Technologies（US）
• Novozymes（Denmark）
• Ginkgo Bioworks（US）
• Amyris（US）
• Precigen, Inc.（US）
• GenScript（China）
• Twist Bioscience（US）
• Synthetic Genomics（US）
• Codexis, Inc.（US）
• Synthego（US）
• Creative Enzymes（US）
• Eurofins Scientific（Luxembourg）
• Bota Biosciences Inc.（China）
• Creative Biogene（US）
• Enbiotix, Inc.（US）
• Illumina, Inc.（US）
• New England Biolabs（US）
• Pareto Bio, Inc.（US）

Global Synthetic Biology Market size was valued at USD 11.3 Billion in 2022 and is poised to grow from USD 14.18 Billion in 2023 to USD 87.27 Billion by 2031, at a CAGR of 25.5% over the forecast period (2024-2031).

The synthetic biology market is poised for robust growth in the coming years, driven largely by technological innovations and an increasing demand for sustainable alternatives. Key advancements in gene editing technologies, particularly Cas9 and CRISPR, along with improvements in synthetic gene synthesis, are enhancing the efficiency and cost-effectiveness of synthetic biology applications. This is further fueled by the rising interest in sustainable solutions, such as green chemicals, biodegradable materials, and biofuels, as environmental concerns and the push for sustainability gain prominence. However, the market faces challenges stemming from ethical and regulatory hurdles, including debates over genetic modifications, environmental impacts, and biosafety, which may hinder both commercialization and ongoing research initiatives. Despite these obstacles, the landscape remains optimistic, particularly with the emergence of advanced therapies and personalized medicine, which hold the promise to revolutionize healthcare by addressing previously untreatable conditions. As such, the synthetic biology market stands at a crossroads, with technological progress and societal demands pushing for innovation, while regulatory frameworks evolve to address ethical considerations.

Top-down and bottom-up approaches were used to estimate and validate the size of the global synthetic biology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

global synthetic biology Market Segmental Analysis

The Global Synthetic Biology Market is segmented by Tool, Application, Technology, and Region. Based on Tool, the market is segmented into Oligonucleotides and Synthetic DNA, Enzymes, Cloning Technologies Kits, Synthetic Cells, Chassis Organisms, and Xeno-Nucleic Acids. Based on Application, the market is segmented into Medical Application, Pharmaceuticals, Drug Discovery and Therapeutics, Other Medical Application, Artificial Tissue and Tissue Regeneration, Industrial Applications, Other Industries, Food & Agriculture, Environmental Applications. Based on Technology, the market is segmented into Gene Synthesis, Genome Engineering, Sequencing, Bioinformatics, Site-directed Mutagenesis, Cloning, Measurement and Modelling, Microfluidics, and Nanotechnology. By Region, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America.

Driver of the global synthetic biology Market

The global synthetic biology market is being significantly driven by the advancements in healthcare and agriculture, where innovative therapies, diagnostics, and vaccines are being developed at an unprecedented pace. The ability of synthetic biology to engineer microorganisms and plants has revolutionized the pharmaceutical sector, enabling the rapid production of targeted treatments and improved diagnostics. Simultaneously, in agriculture, genetically tailored crops designed for enhanced resistance against diseases and pests contribute to greater agricultural productivity and food security, addressing critical global challenges. This dual impact on healthcare and agriculture not only sparks market growth but also fosters broader societal benefits, thereby driving further investment and innovation in synthetic biology.

Restraints in the global synthetic biology Market

The high initial costs associated with the development of synthetic biology technologies serve as a significant market restraint for the global synthetic biology market. These financial barriers limit scalability and accessibility, particularly for smaller companies and emerging economies. Additionally, the complexities involved in engineering, designing, and integrating synthetic biological systems pose substantial challenges, potentially undermining the reliability and efficiency of these technologies. As a result, these factors could deter investment and innovation, slowing the overall growth of the market and limiting the effectiveness of synthetic biology solutions in addressing various biotechnological needs.

Market Trends of the global synthetic biology Market

The global synthetic biology market is increasingly trending towards the integration of epigenetic technologies, as new entrants strive to address the complexities of engineered gene expression. The dynamic interplay of epigenetics and DNA sequences often leads to inconsistent outcomes, prompting innovative solutions that enhance the reliability and predictability of synthetic constructs. Startups and established firms alike are leveraging advancements in epigenetic engineering to refine genetic modifications, ensuring better control over gene activity. This focus on epigenetics is expected to drive growth in the sector, as it enables developers to create more sophisticated and effective biotechnological applications across various industries.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Patent Analysis
• Pricing Analysis
• Regulatory Analysis
• Value Chain Analysis
• Ecosystem of the Market
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Synthetic Biology Market by Tool

• Market Overview
• Oligonucleotides and Synthetic DNA
• Enzymes
• Cloning Technologies Kits
• Synthetic Cells
• Chassis Organisms
• Xeno-nucleic Acids

Synthetic Biology Market by Technology

• Market Overview
• Gene Synthesis
• Genome Engineering
• Sequencing, Bioinformatics
• Site-directed Mutagenesis
• Cloning
• Measurement and Modelling
• Microfluidics
• Nanotechnology

Synthetic Biology Market by Application

• Market Overview

Synthetic Biology Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • Italy
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• [if !supportLists] [endif] Thermo Fisher Scientific, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novozymes (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ginkgo Bioworks (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amyris (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Precigen, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Twist Bioscience (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synthetic Genomics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Codexis, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synthego (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Enzymes (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bota Biosciences Inc. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Biogene (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Enbiotix, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pareto Bio, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments